Guangzhou Boji Medical and Biotechnological Co Ltd Total Liabilities
Guangzhou Boji Medical and Biotechnological Co Ltd total liabilities. Based on the latest financial reports, Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has total liabilities worth CN¥569.21 Million CNY (≈ $83.29 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guangzhou Boji Medical and Biotechnologi liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)
Total liabilities of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025. This chart illustrates how Guangzhou Boji Medical and Biotechnological Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Guangzhou Boji Medical and Biotechnologi (300404) investment intensity to see how much of total assets are deployed in long-term investments.
Guangzhou Boji Medical and Biotechnological Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangzhou Boji Medical and Biotechnological Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sanxiang Co Ltd
SHE:000863
|
China | CN¥1.86 Billion |
|
Fujian Zhangzhou Development Co Ltd
SHE:000753
|
China | CN¥9.03 Billion |
|
OneSpan Inc
NASDAQ:OSPN
|
USA | $113.54 Million |
|
Global Infotech Co Ltd
SHE:300465
|
China | CN¥622.44 Million |
|
Hyundai Energy Solutions Co Ltd
KO:322000
|
Korea | ₩112.65 Billion |
|
2G Energy AG
XETRA:2GB
|
Germany | €120.19 Million |
|
Inti Bangun Sejahtera Tbk
JK:IBST
|
Indonesia | Rp2.01 Trillion |
|
YCC CORP
KQ:232140
|
Korea | ₩122.69 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Guangzhou Boji Medical and Biotechnological Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Guangzhou Boji Medical and Biotechnologi.
Liquidity & Leverage Metrics
Guangzhou Boji Medical and Biotechnological Co Ltd Total Liabilities Ratios Explained
Guangzhou Boji Medical and Biotechnological Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangzhou Boji Medical and Biotechnological Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)
The table below shows the annual total liabilities of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥569.88 Million ≈ $83.39 Million |
+26.97% |
| 2024-12-31 | CN¥448.84 Million ≈ $65.68 Million |
+0.00% |
| 2023-12-31 | CN¥448.82 Million ≈ $65.68 Million |
+19.14% |
| 2022-12-31 | CN¥376.71 Million ≈ $55.12 Million |
+29.08% |
| 2021-12-31 | CN¥291.83 Million ≈ $42.70 Million |
+10.28% |
| 2020-12-31 | CN¥264.64 Million ≈ $38.72 Million |
+49.51% |
| 2019-12-31 | CN¥177.00 Million ≈ $25.90 Million |
-2.91% |
| 2018-12-31 | CN¥182.31 Million ≈ $26.68 Million |
+13.68% |
| 2017-12-31 | CN¥160.37 Million ≈ $23.47 Million |
+80.17% |
| 2016-12-31 | CN¥89.01 Million ≈ $13.02 Million |
+1.76% |
| 2015-12-31 | CN¥87.47 Million ≈ $12.80 Million |
-4.70% |
| 2014-12-31 | CN¥91.78 Million ≈ $13.43 Million |
+4.16% |
| 2013-12-31 | CN¥88.12 Million ≈ $12.89 Million |
+39.78% |
| 2012-12-31 | CN¥63.04 Million ≈ $9.22 Million |
-- |
About Guangzhou Boji Medical and Biotechnological Co Ltd
Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. The company offers pre-clinical research, clinical research, and other consulting services. It also provides clinical drug production, pilot test scale-up, process verification batch … Read more